14Jul
Mylan and Pfizer’s Upjohn Unit Unveil New Branding For Joint Operation
We have previously reported that Mylan and Upjohn, Pfizer’s off-patent branded and generic business, are combining to form a new company. We also reported that although the planned integration has been delayed because of the COVID-19 pandemic, the transaction is expected to close in the second half of 2020....
By:
Goodwin
Related
. . . if they do it right. (Part 3 of a four-part series.) The National Labor Relations Board rece...
Read More >
Buyout firms and portfolio companies should take note of heightened scrutiny of HR and employment pr...
Read More >
The oil price plunge starting on March 6 seems like a sucker-punch to the oil and gas industry after...
Read More >
In its recent complaint challenging the $360 million acquisition of Farelogix by Sabre, the Departme...
Read More >
On October 21, 2019, significant changes to New South Wales ("NSW") security of payment laws come in...
Read More >
In recent years, many defined benefit (“DB”) pension plan sponsors have taken action to limit ongo...
Read More >